Rational Vaccines (Series A+)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$67,000,000
Company Info
Founders
Agustin Fernandez
Market
Healthcare & Wellness
Coinvestors
Presight Capital
Company Description

An investigational-stage infectious disease company focused on combating all diseases resulting from herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) infections. Rational Vaccines is a pre-clinical stage that develops live-attenuated herpes simplex virus vaccines.

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to Healthcare and Biotech DealsView Funding Announcement